Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 8,516 | 7,193 | 3,204 | 5,643 | 1,913 |
| Gross Profit | 8,516 | 7,193 | 3,204 | 5,643 | 1,913 |
| Operating Expenses | 21,779 | 17,924 | 13,693 | 12,104 | 8,884 |
| Operating Income | -13,263 | -10,731 | -10,489 | -6,461 | -6,971 |
| Interest Expense | 203 | 218 | 217 | 215 | 214 |
| Other Income | 52 | 51 | 63 | 334 | 1,048 |
| Pre-tax Income | -13,414 | -10,898 | -10,643 | -6,342 | -6,137 |
| Income Tax | 80 | 131 | N/A | N/A | N/A |
| Net Income Continuous | -13,494 | -11,029 | -10,643 | -6,342 | -6,137 |
| Net Income | $-13,494 | $-11,029 | $-10,643 | $-6,342 | $-6,137 |
| EPS Basic Total Ops | -0.55 | -0.46 | -0.45 | -0.23 | -0.28 |
| EPS Basic Continuous Ops | -0.55 | -0.46 | -0.45 | -0.23 | -0.28 |
| EPS Diluted Total Ops | -0.55 | -0.46 | -0.45 | -0.23 | -0.28 |
| EPS Diluted Continuous Ops | -0.55 | -0.46 | -0.45 | -0.23 | -0.28 |
| EBITDA(a) | $-12,916 | $-10,377 | $-10,106 | $-6,139 | $-6,833 |